greeksoup/ stock research
Stock research / United States / ANIP / Filings

ANI Pharmaceuticals Inc. SEC filings

ANI Pharmaceuticals (ANIP) filed its 10-Q for the quarter ended 30 June 2026 on 7 August 2026. Its latest SEC filing, on 24 August 2026, was an 8-K: officer or director change. 20 filings in the last twelve months, each 8-K by what it was about; the 10-K and proxy statement are on the documents page.

In the twelve months since 11 October 2025 ANI Pharmaceuticals Inc. filed 20 documents with the SEC of the kinds listed here: 12 current reports (8-K), about 6 results of operations; 6 regulation FD disclosure; 3 officer or director change; 1 shareholder vote; 1 change of auditor; 3 quarterly reports (10-Q), 1 employee share plan registration (S-8), 1 annual report to shareholders (ARS), 1 additional proxy material (DEFA14A), 1 proxy statement (DEF 14A), 1 annual report (10-K). The latest, filed 24 August 2026: 8-K, officer or director change. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.

FiledFormWhat it was aboutPeriod or event dateFiling
24 August 20268-KOfficer or director change19 August 2026EDGAR
7 August 202610-Qquarterly report30 June 2026EDGAR
7 August 20268-KResults of operations, Regulation FD disclosure7 August 2026EDGAR
17 July 2026S-8employee share plan registrationEDGAR
21 May 20268-KOfficer or director change, Shareholder vote21 May 2026EDGAR
13 May 20268-KRegulation FD disclosure13 May 2026EDGAR
8 May 202610-Qquarterly report31 March 2026EDGAR
8 May 20268-KResults of operations8 May 2026EDGAR
9 April 2026ARSannual report to shareholders31 December 2025EDGAR
9 April 2026DEFA14Aadditional proxy materialEDGAR
9 April 2026DEF 14Aproxy statement31 December 2025EDGAR
7 April 20268-KChange of auditor1 April 2026EDGAR
3 March 20268-KRegulation FD disclosure3 March 2026EDGAR
27 February 202610-Kannual report31 December 2025EDGAR
27 February 20268-KResults of operations27 February 2026EDGAR
12 January 20268-KResults of operations, Regulation FD disclosure12 January 2026EDGAR
1 December 20258-KOfficer or director change, Regulation FD disclosure24 November 2025EDGAR
10 November 20258-KResults of operations, Regulation FD disclosure10 November 2025EDGAR
7 November 202510-Qquarterly report30 September 2025EDGAR
7 November 20258-KResults of operations7 November 2025EDGAR
An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.

Source

The company's filing index on EDGAR, read from the SEC's submissions feed.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install